Literature DB >> 19191133

Determining the time to maximal bronchodilator response in asthmatic children.

Vaska Stavreska1, Maureen Verheggen, Jan Oostryck, Stephen M Stick, Graham L Hall.   

Abstract

BACKGROUND: The interval between bronchodilator administration and post-bronchodilator lung function testing is critical for accurate interpretation of the bronchodilator response. The time course of this response in children is not well documented. We aimed to document the time taken to achieve maximal lung function following salbutamol inhalation.
METHODS: Eighteen asthmatic children between 7 and 18 years of age with a history of bronchodilator responsiveness were recruited. Spirometry was performed before and at 0, 10, 15, 20, 40, 60, and 90 minutes after salbutamol inhalation 600 microg (Ventolin; GlaxoSmithKline) via a spacer (Volumatic; GlaxoSmithKline).
RESULTS: Spirometric indices significantly increased after salbutamol inhalation (p < 0.001). The group median time to maximal response in forced expiratory volume in 1 second (FEV(1)) was 17.5 (10-60: 10th-90th centiles) minutes after salbutamol. The magnitude of group response in FEV(1) was significantly higher at 15 and 20 minutes than at 0 and 10 minutes post-salbutamol inhalation (repeat measures analysis of variance [ANOVA] on ranks; p < 0.05).
CONCLUSION: We conclude that a minimal interval of 20 minutes, before re-testing spirometry, is required to document the maximal response to bronchodilators in the majority of asthmatic children.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19191133     DOI: 10.1080/02770900802460555

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  3 in total

1.  The relationship of the bronchodilator response phenotype to poor asthma control in children with normal spirometry.

Authors:  Stanley P Galant; Tricia Morphew; Robert L Newcomb; Kiem Hioe; Olga Guijon; Otto Liao
Journal:  J Pediatr       Date:  2011-01-13       Impact factor: 4.406

2.  Effect of Albuterol Premedication vs Placebo on the Occurrence of Respiratory Adverse Events in Children Undergoing Tonsillectomies: The REACT Randomized Clinical Trial.

Authors:  Britta S von Ungern-Sternberg; David Sommerfield; Lliana Slevin; Thomas F E Drake-Brockman; Guicheng Zhang; Graham L Hall
Journal:  JAMA Pediatr       Date:  2019-06-01       Impact factor: 16.193

3.  Determining the optimal time to assess the reversibility of airway obstruction.

Authors:  Jamel El Ghoul; Maher Abouda; Meriem Triki; Abdessalem Ghourabi; Ridha Charfi
Journal:  Lung India       Date:  2019 Mar-Apr
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.